Banner

The impact of increased body mass index on outcome and quality of life after valve replacement

• 2022
Back
Publication Information
Authors Ehab Salem, Mohammed Elgazzar, Noha Helal, Ashraf Wahdan
Keywords Not Available
Journal Not Available
Publisher Not Available
Volume Not Available
Issue Not Available
Pages Not Available
publication.type Local
Paper Link Not Available
Supplementary Materials Not Available
Abstract
Background: The association between obesity and the outcomes of surgery is
controversial. This study aimed to assess the effect of body mass index (BMI) on early
and late morbidity and mortality after valve replacement surgery.
Methods: The study was conducted on 100 valve replacement patients from 2020
to 2022. The patients were divided according to BMI into two groups: patients with
morbid obesity (BMI ≥ 35) (Group A: n = 50) and patients who had BMI< 35 (Group
B.; n = 50).
Results: Hospital (9.43 ± 5.93 vs. 7.25 ± 4.05 days, P= 0.034), ICU length of stay (7.32
± 5.67 vs. 4.52 ± 3.24 days, P= 0.003), and duration of mechanical ventilation (3.58 ±
2.54 vs. 2.342 ± 2.05 days, P= 0.008) were significantly higher in Group A. There was
no significant difference in postoperative mortality between both groups (P= 0.678).
There was no significant difference in morbidity and mortality after a 3-month
follow-up. Hemoglobin was significantly lower in Group A (P =0.034), with no
difference in postoperative laboratory investigations.
Conclusions: Morbid obesity was not associated with increased mortality after valve
replacement surgery; however, it could increase the duration of ventilation, ICU, and
hospital stay.